BSE Live
Dec 26, 16:01Prev. Close
1968.35
Open Price
1963.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:53Prev. Close
1970.10
Open Price
1970.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1915.80 (24)
| Balance Sheet of Caplin Point Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 9 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 15.13 | 15.13 | 15.12 | 15.12 | 15.11 | |
| Total Share Capital | 15.13 | 15.13 | 15.12 | 15.12 | 15.11 | |
| Reserves and Surplus | 848.76 | 575.01 | 345.42 | 209.56 | 109.29 | |
| Total Reserves and Surplus | 848.76 | 575.01 | 345.42 | 209.56 | 113.03 | |
| Total Shareholders Funds | 873.33 | 596.99 | 363.83 | 224.76 | 128.14 | |
| Minority Interest | 8.66 | 0.08 | 0.09 | 0.36 | 0.27 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.02 | 0.29 | 0.32 | 0.48 | 0.73 | |
| Deferred Tax Liabilities [Net] | 10.11 | 17.62 | 22.16 | 18.97 | 11.33 | |
| Other Long Term Liabilities | 14.73 | 5.51 | 5.38 | 0.05 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.40 | 1.63 | |
| Total Non-Current Liabilities | 24.86 | 23.42 | 27.86 | 19.90 | 13.69 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 36.46 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 64.14 | 60.47 | 94.23 | 78.60 | 57.24 | |
| Other Current Liabilities | 42.82 | 24.20 | 13.86 | 33.09 | 60.39 | |
| Short Term Provisions | 0.91 | 1.44 | 0.58 | 1.67 | 7.41 | |
| Total Current Liabilities | 144.32 | 86.11 | 108.67 | 113.36 | 125.04 | |
| Total Capital And Liabilities | 1,125.76 | 742.52 | 500.45 | 358.38 | 267.14 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 267.44 | 224.73 | 167.42 | 150.46 | 143.63 | |
| Intangible Assets | 5.07 | 2.11 | 2.07 | 1.37 | 0.60 | |
| Capital Work-In-Progress | 20.12 | 9.70 | 15.29 | 3.42 | 0.23 | |
| Fixed Assets | 292.62 | 236.55 | 184.77 | 155.25 | 144.46 | |
| Non-Current Investments | 0.56 | 0.33 | 0.33 | 13.24 | 0.44 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 5.38 | 10.65 | 9.11 | 10.67 | 3.71 | |
| Other Non-Current Assets | 4.67 | 1.30 | 2.12 | 0.00 | 0.00 | |
| Total Non-Current Assets | 303.23 | 248.83 | 196.34 | 179.16 | 148.61 | |
| CURRENT ASSETS | ||||||
| Current Investments | 60.23 | 69.62 | 46.34 | 4.20 | 0.00 | |
| Inventories | 238.23 | 37.45 | 28.46 | 22.29 | 18.81 | |
| Trade Receivables | 228.96 | 159.81 | 125.88 | 33.02 | 7.95 | |
| Cash And Cash Equivalents | 223.43 | 152.99 | 79.28 | 93.07 | 68.10 | |
| Short Term Loans And Advances | 68.30 | 72.88 | 23.85 | 24.00 | 21.15 | |
| OtherCurrentAssets | 3.38 | 0.95 | 0.31 | 2.63 | 2.52 | |
| Total Current Assets | 822.53 | 493.69 | 304.11 | 179.22 | 118.53 | |
| Total Assets | 1,125.76 | 742.52 | 500.45 | 358.38 | 267.14 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 51.99 | 83.87 | 67.48 | 83.41 | 7.64 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.04 | 0.04 | 12.95 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.23 | 0.29 | 0.30 | 0.30 | 0.30 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 60.56 | 69.62 | 46.34 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 5.42 | 0.00 | 0.00 | 4.20 | 0.00 |
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
28.08.2025
21.08.2025
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
15.05.2025
Caplin Labs Consolidated March 2025 Net Sales at Rs 502.45 crore, up 10.86% Y-o-Y